Polymers for Nucleic Acid Transfer-An Overview

Advances in Genetics

Volumn 88, Issue , 2014, Pages 231-261

  Wagner, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cationic polymers; Gene transfer; PDNA; Receptor targeting; SiRNA

Indexed keywords

BIOMATERIAL; DNA; MESSENGER RNA; NANOPARTICLE; POLYAMINE; POLYCATIONS; POLYMER; SMALL INTERFERING RNA;

ANIMAL; BIOAVAILABILITY; CHEMISTRY; ENDOSOME; GENE TRANSFER; GENETICS; HUMAN; METABOLISM;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; DNA; ENDOSOMES; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES; POLYAMINES; POLYMERS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84910006690     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800148-6.00008-0     Document Type: Chapter

References (212)

1. Ahn C.H., Chae S.Y., Bae Y.H., Kim S.W. Biodegradable poly(ethylenimine) for plasmid DNA delivery. The Journal of Controlled Release 2002, 80(1-3):273-282.
2. Akinc A., Anderson D.G., Lynn D.M., Langer R. Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery. Bioconjugate Chemistry 2003, 14(5):979-988.
3. Akinc A., Lynn D.M., Anderson D.G., Langer R. Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. Journal of the American Chemical Society 2003, 125(18):5316-5323.
4. Akinc A., Thomas M., Klibanov A.M., Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. The Journal of Gene Medicine 2005, 7(5):657-663.
5. Akinc A., Zumbuehl A., Goldberg M., Leshchiner E.S., Busini V., Hossain N., et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nature Biotechnology 2008, 26(5):561-569.
6. Anderson D.G., Akinc A., Hossain N., Langer R. Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Molecular Therapy 2005, 11(3):426-434.
7. Anderson D.G., Lynn D.M., Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angewandte Chemie International Edition in English 2003, 42(27):3153-3158.
8. Anwer K., Barnes M.N., Fewell J., Lewis D.H., Alvarez R.D. Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer. Gene Therapy 2010, 17(3):360-369. 10.1038/gt.2009.159.
9. Arima H., Kihara F., Hirayama F., Uekama K. Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins. Bioconjugate Chemistry 2001, 12(4):476-484.
10. Behr J.P. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 1997, 51(1-2):34-36.
11. Bellocq N.C., Pun S.H., Jensen G.S., Davis M.E. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjugate Chemistry 2003, 14(6):1122-1132.
12. Benjaminsen R.V., Mattebjerg M.A., Henriksen J.R., Moghimi S.M., Andresen T.L. The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH. Molecular Therapy 2013, 21(1):149-157. 10.1038/mt.2012.185.
13. Bertrand E., Goncalves C., Billiet L., Gomez J.P., Pichon C., Cheradame H., et al. Histidinylated linear PEI: a new efficient non-toxic polymer for gene transfer. Chemical Communications (Cambridge) 2011, 47(46):12547-12549. 10.1039/c1cc15716g.
14. Blacklock J., Vetter A., Lankenau A., Oupicky D., Mohwald H. Tuning the mechanical properties of bioreducible multilayer films for improved cell adhesion and transfection activity. Biomaterials 2010, 31(27):7167-7174. 10.1016/j.biomaterials.2010.06.002.
15. Blessing T., Kursa M., Holzhauser R., Kircheis R., Wagner E. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjugate Chemistry 2001, 12(4):529-537.
16. Boeckle S., von Gersdorff K., van der Piepen S., Culmsee C., Wagner E., Ogris M. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. The Journal of Gene Medicine 2004, 6(10):1102-1111.
17. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and invivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(16):7297-7301.
18. Breunig M., Lungwitz U., Liebl R., Goepferich A. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(36):14454-14459.
19. Brown M.D., Schatzlein A.G., Uchegbu I.F. Gene delivery with synthetic (non viral) carriers. International Journal of Pharmaceutics 2001, 229(1-2):1-21.
20. Brunner S., Furtbauer E., Sauer T., Kursa M., Wagner E. Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Molecular Therapy 2002, 5(1):80-86.
21. Carlisle R.C., Etrych T., Briggs S.S., Preece J.A., Ulbrich K., Seymour L.W. Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. The Journal of Gene Medicine 2004, 6(3):337-344.
22. Chang K.L., Higuchi Y., Kawakami S., Yamashita F., Hashida M. Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape. Bioconjugate Chemistry 2010, 21(6):1087-1095. 10.1021/bc1000609.
23. Chattoraj D.K., Gosule L.C., Schellman A. DNA condensation with polyamines. II. Electron microscopic studies 95. Journal of Molecular Biology 1978, 121:327-337.
24. Chen C.P., Kim J.S., Steenblock E., Liu D., Rice K.G. Gene transfer with poly-melittin peptides. Bioconjugate Chemistry 2006, 17(4):1057-1062.
25. Chen Q.R., Zhang L., Stass S.A., Mixson A.J. Branched co-polymers of histidine and lysine are efficient carriers of plasmids. Nucleic Acids Research 2001, 29(6):1334-1340.
26. Choi S., Lee K.D. Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. The Journal of Controlled Release 2008, 131(1):70-76.
27. Choi J.S., Nam K., Park J.-y., Kim J.-B., Lee J.-K., Park J.-S. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. The Journal of Controlled Release 2004, 99(3):445-456.
28. Christensen L.V., Chang C.W., Kim W.J., Kim S.W., Zhong Z., Lin C., et al. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjugate Chemistry 2006, 17(5):1233-1240.
29. Coll J.L., Chollet P., Brambilla E., Desplanques D., Behr J.P., Favrot M. Invivo delivery to tumors of DNA complexed with linear polyethylenimine. Human Gene Therapy 1999, 10(10):1659-1666.
30. Cotten M., Langle-Rouault F., Kirlappos H., Wagner E., Mechtler K., Zenke M., et al. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(11):4033-4037.
31. Cotten M., Wagner E., Zatloukal K., Birnstiel M.L. Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. Journal of Virology 1993, 67(7):3777-3785.
32. Creusat G., Rinaldi A.S., Weiss E., Elbaghdadi R., Remy J.S., Mulherkar R., et al. Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems. Bioconjugate Chemistry 2010, 21(5):994-1002. 10.1021/bc100010k.
33. Creusat G., Thomann J.S., Maglott A., Pons B., Dontenwill M., Guerin E., et al. Pyridylthiourea-grafted polyethylenimine offers an effective assistance to siRNA-mediated gene silencing invitro and invivo. The Journal of Controlled Release 2012, 157(3):418-426. pii:S0168-3659(11)00959-X. 10.1016/j.jconrel.2011.10.007.
34. Creusat G., Zuber G. Self-assembling polyethylenimine derivatives mediate efficient siRNA delivery in mammalian cells. Chembiochem 2008, 9(17):2787-2789. 10.1002/cbic.200800540.
35. Cryan S.A., Holohan A., Donohue R., Darcy R., O'Driscoll C.M. Cell transfection with polycationic cyclodextrin vectors. European Journal of Pharmaceutical Sciences 2004, 21(5):625-633.
36. Curiel D.T., Agarwal S., Wagner E., Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(19):8850-8854.
37. Curiel D.T., Wagner E., Cotten M., Birnstiel M.L., Agarwal S., Li C.M., et al. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Human Gene Therapy 1992, 3(2):147-154.
38. Dahlman J.E., Kauffman K.J., Langer R., Anderson D.G. Nanotechnology for invivo targeted siRNA delivery 2014, (Chapter in current volume).
39. Dang J.M., Leong K.W. Natural polymers for gene delivery and tissue engineering. Advanced Drug Delivery Reviews 2006, 58(4):487-499.
40. Davis M.E. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Molecular Pharmaceutics 2009, 6(3):659-668. 10.1021/mp900015y.
41. Davis P.B., Cooper M.J. Vectors for airway gene delivery. AAPS Journals 2007, 9(1):E11-E17.
42. Davis M.E., Zuckerman J.E., Choi C.H., Seligson D., Tolcher A., Alabi C.A., et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464:1067-1070. pii:nature08956. 10.1038/nature08956.
43. Dohmen C., Edinger D., Frohlich T., Schreiner L., Lachelt U., Troiber C., et al. Nanosized multifunctional polyplexes for receptor-mediated SiRNA delivery. ACS Nano 2012, 6(6):5198-5208. 10.1021/nn300960m.
44. Dufes C., Keith W.N., Bilsland A., Proutski I., Uchegbu I.F., Schatzlein A.G. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Research 2005, 65(18):8079-8084.
45. Dufès C., Uchegbu I.F., Schätzlein A.G. Dendrimers in gene delivery. Advanced Drug Delivery Reviews 2005, 57(15):2177-2202. 10.1016/j.addr.2005.09.017.
46. Erbacher P., Roche A.C., Monsigny M., Midoux P. Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosilated polylysines and the plasmid size 180. Bioconjugate Chemistry 1995, 6:401-410.
47. Erbacher P., Zou S., Bettinger T., Steffan A.M., Remy J.S. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability 826. Pharmaceutical Research 1998, 15(9):1332-1339.
48. Farber F.E., Melnick J.L., Butel J.S. Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochimica et Biophysica Acta 1975, 390(3):298-311.
49. Felgner P.L., Barenholz Y., Behr J.P., Cheng S.H., Cullis P., Huang L., et al. Nomenclature for synthetic gene delivery systems. Human Gene Therapy 1997, 8(5):511-512. 10.1089/hum.1997.8.5-511.
50. Fella C., Walker G.F., Ogris M., Wagner E. Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding. European Journal of Pharmaceutical Sciences 2008, 34(4-5):309-320.
51. Ferkol T., Kaetzel C.S., Davis P.B. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. The Journal of Clinical Investigation 1993, 92(5):2394-2400.
52. Fewell J.G., Matar M.M., Rice J.S., Brunhoeber E., Slobodkin G., Pence C., et al. Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally. The Journal of Gene Medicine 2009, 11(8):718-728. 10.1002/jgm.1356.
53. Fischer W., Calderon M., Schulz A., Andreou I., Weber M., Haag R. Dendritic polyglycerols with oligoamine shells show low toxicity and high siRNA transfection efficiency invitro. Bioconjugate Chemistry 2010, 21(10):1744-1752. 10.1021/bc900459n.
54. Fisher K.D., Ulbrich K., Subr V., Ward C.M., Mautner V., Blakey D., et al. A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Therapy 2000, 7(15):1337-1343.
55. Forrest M.L., Koerber J.T., Pack D.W. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chemistry 2003, 14(5):934-940.
56. Fröhlich T., Edinger D., Kläger R., Troiber C., Salcher E., Badgujar N., et al. Structure-activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides. The Journal of Controlled Release 2012, 160(3):532-541. pii:S0168-3659(12)00206-4. 10.1016/j.jconrel.2012.03.018.
57. Frohlich T., Edinger D., Russ V., Wagner E. Stabilization of polyplexes via polymer crosslinking for efficient siRNA delivery. European Journal of Pharmaceutical Sciences 2012, 47(5):914-920. pii:S0928-0987(12)00358-2. 10.1016/j.ejps.2012.09.006.
58. Germershaus O., Mao S., Sitterberg J., Bakowsky U., Kissel T. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships invitro. The Journal of Controlled Release 2008, 125(2):145-154.
59. Gibson D.G., Glass J.I., Lartigue C., Noskov V.N., Chuang R.Y., Algire M.A., et al. Creation of a bacterial cell controlled by a chemically synthesized genome. Science 2010, 329(5987):52-56. 10.1126/science.1190719.
60. Gofrit O.N., Benjamin S., Halachmi S., Leibovitch I., Dotan Z., Lamm D.L., et al. DNA based therapy with Diphtheria Toxin-a BC-819: a phase 2b marker lesion trial in patients with Intermediate Risk Nonmuscle Invasive bladder Cancer. The Journal of Urology 2014, 191(6):1697-1702. 10.1016/j.juro.2013.12.011.
61. Gomez J.P., Pichon C., Midoux P. Ability of plasmid DNA complexed with histidinylated lPEI and lPEI to cross invitro lung and muscle vascular endothelial barriers. Gene 2013, 525(2):182-190. 10.1016/j.gene.2013.03.055.
62. Goncalves C., Pichon C., Guerin B., Midoux P. Intracellular processing and stability of DNA complexed with histidylated polylysine conjugates. The Journal of Gene Medicine 2002, 4(3):271-281.
63. Gosselin M.A., Guo W., Lee R.J. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjugate Chemistry 2001, 12(6):989-994.
64. Grandinetti G., Ingle N.P., Reineke T.M. Interaction of poly(ethylenimine)-DNA polyplexes with mitochondria: implications for a mechanism of cytotoxicity. Molecular Pharmaceutics 2011, 8(5):1709-1719. 10.1021/mp200078n.
65. Haensler J., Szoka F.C. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chemistry 1993, 4:372-379.
66. Hall A., Larsen A.K., Parhamifar L., Meyle K.D., Wu L.P., Moghimi S.M. High resolution respirometry analysis of polyethylenimine-mediated mitochondrial energy crisis and cellular stress: Mitochondrial proton leak and inhibition of the electron transport system. Biochimica et Biophysica Acta 2013, 1827(10):1213-1225. 10.1016/j.bbabio.2013.07.001.
67. Han S., Mahato R.I., Sung Y.K., Kim S.W. Development of biomaterials for gene therapy. Molecular Therapy 2000, 2(4):302-317.
68. Hartmann L., Börner H.G. Precision polymers: Monodisperse, Monomer-sequence-defined Segments to target Future Demands of polymers in medicine. Advanced Materials 2009, 21(32-33):3425-3431. 10.1002/adma.200801884.
69. Hartmann L., Häfele S., Peschka-Süss R., Antonietti M., Börner H.G. Sequence Positioning of disulfide linkages to Program the Degradation of Monodisperse Poly(amidoamines). Macromolecules 2007, 40(22):7771-7776. 10.1021/ma071427u.
70. Hartmann L., Hafele S., Peschka-Suss R., Antonietti M., Borner H.G. Tailor-made Poly(amidoamine)s for controlled complexation and condensation of DNA. Chemistry 2008, 14(7):2025-2033.
71. Hartmann L., Krause E., Antonietti M., Borner H.G. Solid-phase supported polymer synthesis of sequence-defined, multifunctional poly(amidoamines). Biomacromolecules 2006, 7(4):1239-1244.
72. Hoon J.J., Christensen L.V., Yockman J.W., Zhong Z., Engbersen J.F., Jong K.W., et al. Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials 2007, 28(10):1912-1917.
73. Hornof M., de la F.M., Hallikainen M., Tammi R.H., Urtti A. Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. The Journal of Gene Medicine 2008, 10(1):70-80.
74. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen M.O., et al. RNA interference invitro and invivo using a novel chitosan/siRNA nanoparticle system. Molecular Therapy 2006, 14(4):476-484. pii:S1525-0016(06)00180-8. 10.1016/j.ymthe.2006.04.010.
75. Hwang S.J., Bellocq N.C., Davis M.E. Effects of structure of beta-cyclodextrin-containing polymers on gene delivery. Bioconjugate Chemistry 2001, 12(2):280-290.
76. Itaka K., Harada A., Yamasaki Y., Nakamura K., Kawaguchi H., Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. The Journal of Gene Medicine 2004, 6(1):76-84.
77. Itaka K., Kataoka K. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. European Journal of Pharmaceutics and Biopharmaceutics 2009, 71(3):475-483. pii:S0939-6411(08)00384-6. 10.1016/j.ejpb.2008.09.019.
78. Ito T., Yoshihara C., Hamada K., Koyama Y. DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 2010, 31(10):2912-2918. pii:S0142-9612(09)01419-7. 10.1016/j.biomaterials.2009.12.032.
79. Kawano T., Okuda T., Aoyagi H., Niidome T. Long circulation of intravenously administered plasmid DNA delivered with dendritic poly(L-lysine) in the blood flow. The Journal of Controlled Release 2004, 99(2):329-337.
80. Kichler A., Leborgne C., Coeytaux E., Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. The Journal of Gene Medicine 2001, 3(2):135-144.
81. Kim T.I., Kim S.W. Bioreducible polymers for gene delivery. Reactive and Functional Polymers 2011, 71(3):344-349. 10.1016/j.reactfunctpolym.2010.11.016.
82. Kim Y.H., Park J.H., Lee M., Park T.G., Kim S.W. Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. The Journal of Controlled Release 2005, 103(1):209-219.
83. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Therapy 1997, 4(5):409-418.
84. Klein P.M., Wagner E. Bioreducible polycations as Shuttles for therapeutic nucleic acid and protein transfection. Antioxidants and Redox Signaling 2014, 21(5):804-817. 10.1089/ars.2013.5714.
85. Kloeckner J., Bruzzano S., Ogris M., Wagner E. Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties. Bioconjugate Chemistry 2006, 17(5):1339-1345.
86. Kloeckner J., Wagner E., Ogris M. Degradable gene carriers based on oligomerized polyamines. European Journal of Pharmaceutical Sciences 2006, 29(5):414-425.
87. Klutz K., Russ V., Willhauck M.J., Wunderlich N., Zach C., Gildehaus F.J., et al. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene. Clinical Cancer Research 2009, 15(19):6079-6086. pii:1078-0432.CCR-09-0851. 10.1158/1078-0432.CCR-09-0851.
88. Knorr V., Allmendinger L., Walker G.F., Paintner F.F., Wagner E. An acetal-based PEGylation reagent for pH-sensitive shielding of DNA polyplexes. Bioconjugate Chemistry 2007, 18(4):1218-1225.
89. Knorr V., Ogris M., Wagner E. An acid sensitive ketal-based polyethylene glycol-oligoethylenimine copolymer mediates improved transfection efficiency at reduced toxicity. Pharmaceutical Research 2008, 25(12):2937-2945.
90. Knorr V., Russ V., Allmendinger L., Ogris M., Wagner E. Acetal linked oligoethylenimines for use as pH-sensitive gene carriers. Bioconjugate Chemistry 2008, 19(8):1625-1634.
91. Konstan M.W., Davis P.B., Wagener J.S., Hilliard K.A., Stern R.C., Milgram L.J., et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Human Gene Therapy 2004, 15(12):1255-1269. 10.1089/hum.2004.15.1255.
92. Koping-Hoggard M., Tubulekas I., Guan H., Edwards K., Nilsson M., Varum K.M., et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine invitro and after lung administration invivo. Gene Therapy 2001, 8(14):1108-1121.
93. Koppu S., Oh Y.J., Edrada-Ebel R., Blatchford D.R., Tetley L., Tate R.J., et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. The Journal of Controlled Release 2010, 143(2):215-221. pii:S0168-3659(09)00791-3. 10.1016/j.jconrel.2009.11.015.
94. Ko I.K., Ziady A., Lu S., Kwon Y.J. Acid-degradable cationic methacrylamide polymerized in the presence of plasmid DNA as tunable non-viral gene carrier. Biomaterials 2008, 29(28):3872-3881.
95. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J., et al. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(10):4897-4902.
96. Kukowska-Latallo J.F., Raczka E., Quintana A., Chen C., Rymaszewski M., Baker J., et al. Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Human Gene Therapy 2000, 11(10):1385-1395.
97. Kursa M., Walker G.F., Roessler V., Ogris M., Roedl W., Kircheis R., et al. Novel shielded Transferrin-Polyethylene glycol-Polyethylenimine/DNA complexes for systemic tumor-targeted gene Transfer. Bioconjugate Chemistry 2003, 14(1):222-231.
98. Kwok A., Hart S.L. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine 2011, 7(2):210-219. pii:S1549-9634(10)00239-X. 10.1016/j.nano.2010.07.005.
99. Lachelt U., Kos P., Mickler F.M., Herrmann A., Salcher E.E., Rodl W., et al. Fine-tuning of proton sponges by precise diaminoethanes and histidines in pDNA polyplexes. Nanomedicine 2014, 10(1):35-44. 10.1016/j.nano.2013.07.008.
100. Lachelt U., Wittmann V., Muller K., Edinger D., Kos P., Hohn M., et al. Synthetic Polyglutamylation of Dual-functional MTX ligands for enhanced combined cytotoxicity of Poly(I: C) Nanoplexes. Molecular Pharmaceutics 2014, 11(8):2631-2639. 10.1021/mp500017u.
101. Laemmli U.K. Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine. Proceedings of the National Academy of Sciences of the United States of America 1975, 72:4288-4292.
102. Lee Y., Koo H., Jin G.W., Mo H., Cho M.Y., Park J.Y., et al. Poly(ethylene oxide sulfide): new poly(ethylene glycol) derivatives degradable in reductive conditions. Biomacromolecules 2005, 6(1):24-26. 10.1021/bm049658l.
103. Lee D., Zhang W., Shirley S.A., Kong X., Hellermann G.R., Lockey R.F., et al. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharmaceutical Research 2007, 24(1):157-167.
104. Leng Q., Mixson A.J. Small interfering RNA targeting Raf-1 inhibits tumor growth invitro and invivo. Cancer Gene Therapy 2005, 12(8):682-690.
105. Leng Q., Scaria P., Zhu J., Ambulos N., Campbell P., Mixson A.J. Highly branched HK peptides are effective carriers of siRNA. The Journal of Gene Medicine 2005, 7(7):977-986.
106. Lim Y.B., Han S.O., Kong H.U., Lee Y., Park J.S., Jeong B., et al. Biodegradable polyester, poly[alpha-(4-aminobutyl)-l-glycolic acid], as a non-toxic gene carrier. Pharmaceutical Research 2000, 17(7):811-816.
107. Lim Y.B., Kim S.M., Suh H., Park J.S. Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjugate Chemistry 2002, 13(5):952-957.
108. Lin C., Blaauboer C.-J., Timoneda M.M., Lok M.C., van Steenbergen M., Hennink W.E., et al. Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. The Journal of Controlled Release 2008, 126(2):166-174. 10.1016/j.jconrel.2007.11.012.
109. Lin C., Zhong Z., Lok M.C., Jiang X., Hennink W.E., Feijen J., et al. Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjugate Chemistry 2007, 18(1):138-145.
110. Lisziewicz J., Bakare N., Calarota S.A., Banhegyi D., Szlavik J., Ujhelyi E., et al. Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals. PLoS One 2012, 7(5):e35416. 10.1371/journal.pone.0035416.
111. Luo K., Li C., Wang G., Nie Y., He B., Wu Y., et al. Peptide dendrimers as efficient and biocompatible gene delivery vectors: synthesis and invitro characterization. The Journal of Controlled Release 2011, 155(1):77-87. 10.1016/j.jconrel.2010.10.006.
112. Lynn D.M., Anderson D.G., Putnam D., Langer R. Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. Journal of the American Chemical Society 2001, 123(33):8155-8156.
113. MacLaughlin F.C., Mumper R.J., Wang J., Tagliaferri J.M., Gill I., Hinchcliffe M., et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for invivo plasmid delivery. The Journal of Controlled Release 1998, 56(1-3):259-272.
114. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., Fernandes J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. European Journal of Pharmaceutics and Biopharmaceutics 2004, 57(1):1-8.
115. Martin I., Dohmen C., Mas-Moruno C., Troiber C., Kos P., Schaffert D., et al. Solid-phase-assisted synthesis of targeting peptide-PEG-oligo(ethane amino)amides for receptor-mediated gene delivery. Organic and Biomolecular Chemistry 2012, 10(16):3258-3268.
116. McCutchan J.H., Pagano J.S. Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. Journal of the National Cancer Institute 1968, 41(2):351-357.
117. McKenzie D.L., Kwok K.Y., Rice K.G. A potent new class of reductively activated peptide gene delivery agents. The Journal of Biological Chemistry 2000, 275(14):9970-9977.
118. Merdan T., Kunath K., Petersen H., Bakowsky U., Voigt K.H., Kopecek J., et al. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under invivo conditions in a dose-dependent manner after intravenous injection into mice. Bioconjugate Chemistry 2005, 16(4):785-792.
119. Merkel O.M., Urbanics R., Bedocs P., Rozsnyay Z., Rosivall L., Toth M., et al. Invitro and invivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. Biomaterials 2011, 32(21):4936-4942. 10.1016/j.biomaterials.2011.03.035.
120. Meyer M., Dohmen C., Philipp A., Kiener D., Maiwald G., Scheu C., et al. Synthesis and biological evaluation of a Bioresponsive and endosomolytic siRNA-Polymer conjugate. Molecular Pharmaceutics 2009, 6(3):752-762. 10.1021/mp9000124.
121. Meyer M., Philipp A., Oskuee R., Schmidt C., Wagner E. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. Journal of the American Chemical Society 2008, 130(11):3272-3273.
122. Meyer M., Wagner E. pH-responsive shielding of non-viral gene vectors. Expert Opinion on Drug Delivery 2006, 3(5):563-571.
123. Midoux P., Breuzard G., Gomez J.P., Pichon C. Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. Current Gene Therapy 2008, 8(5):335-352.
124. Midoux P., Monsigny M. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjugate Chemistry 1999, 10(3):406-411.
125. Miyata K., Nishiyama N., Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chemical Society Reviews 2012, 41(7):2562-2574.
126. Moghimi S.M., Symonds P., Murray J.C., Hunter A.C., Debska G., Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Molecular Therapy 2005, 11(6):990-995.
127. Murthy N., Campbell J., Fausto N., Hoffman A.S., Stayton P.S. Bioinspired pH-responsive polymers for the intracellular delivery of Biomolecular drugs. Bioconjugate Chemistry 2003, 14(2):412-419.
128. Murthy N., Campbell J., Fausto N., Hoffman A.S., Stayton P.S. Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. The Journal of Controlled Release 2003, 89(3):365-374.
129. Neuberg P., Kichler A. Recent developments in nucleic acid delivery with polyethylenimines 2014, (Chapter in current volume).
130. Noga M., Edinger D., Rodl W., Wagner E., Winter G., Besheer A. Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase. The Journal of Controlled Release 2012, 159(1):92-103. pii:S0168-3659(12)00011-9. 10.1016/j.jconrel.2012.01.006.
131. Ogris M., Steinlein P., Kursa M., Mechtler K., Kircheis R., Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Therapy 1998, 5(10):1425-1433.
132. Ogris M., Wagner E. To be targeted: is the magic bullet concept a viable option for synthetic nucleic Acid therapeutics?. Human Gene Therapy 2011, 22(7):799-807. 10.1089/hum.2011.065.
133. Ohana P., Gofrit O., Ayesh S., Al-Sharef W., Mizrahi A., Birman T., et al. Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer. Gene Therapy and Molecular Biology 2004, 8:181-192.
134. Ohsaki M., Okuda T., Wada A., Hirayama T., Niidome T., Aoyagi H. Vitro gene transfection using dendritic Poly(l-lysine). Bioconjugate Chemistry 2002, 13(3):510-517. 10.1021/bc015525a.
135. Okuda T., Sugiyama A., Niidome T., Aoyagi H. Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers invitro. Biomaterials 2004, 25(3):537-544.
136. Pack D.W., Hoffman A.S., Pun S., Stayton P.S. Design and development of polymers for gene delivery. Nature Reviews Drug Discovery 2005, 4(7):581-593.
137. Park T.G., Jeong J.H., Kim S.W. Current status of polymeric gene delivery systems. Advanced Drug Delivery Reviews 2006, 58(4):467-486.
138. Park I.K., Kim T.H., Park Y.H., Shin B.A., Choi E.S., Chowdhury E.H., et al. Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier. The Journal of Controlled Release 2001, 76(3):349-362.
139. Ping Y., Hu Q., Tang G., Li J. FGFR-targeted gene delivery mediated by supramolecular assembly between beta-cyclodextrin-crosslinked PEI and redox-sensitive PEG. Biomaterials 2013, 34(27):6482-6494. 10.1016/j.biomaterials.2013.03.071.
140. Plank C., Mechtler K., Szoka F.C., Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Human Gene Therapy 1996, 7(12):1437-1446.
141. Plank C., Zatloukal K., Cotten M., Mechtler K., Wagner E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chemistry 1992, 3(6):533-539.
142. Plank C., Zauner W., Wagner E. Application of membrane-active peptides for drug and gene delivery across cellular membranes. Advanced Drug Delivery Reviews 1998, 34(1):21-35.
143. Pun S.H., Bellocq N.C., Liu A., Jensen G., Machemer T., Quijano E., et al. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjugate Chemistry 2004, 15(4):831-840.
144. Read M.L., Bremner K.H., Oupický D., Green N.K., Searle P.F., Seymour L.W. Vectors based on reducible polycations facilitate intracellular release of nucleic acids. The Journal of Gene Medicine 2003, 5(3):232-245. 10.1002/jgm.331.
145. Reineke T.M., Davis M.E. Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center type. Bioconjugate Chemistry 2003, 14(1):255-261.
146. Remaut K., Symens N., Lucas B., Demeester J., De Smedt S.C. Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?. The Journal of Controlled Release 2014, 179:1-9. 10.1016/j.jconrel.2014.01.013.
147. Rodriguez B., Asmuth D.M., Matining R.M., Spritzler J., Jacobson J.M., Mailliard R.B., et al. Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial. Journal of Acquired Immune Deficiency Syndromes 2013, 64(4):351-359. 10.1097/QAI.0b013e3182a99590.
148. Rozema D.B., Lewis D.L., Wakefield D.H., Wong S.C., Klein J.J., Roesch P.L., et al. Dynamic PolyConjugates for targeted invivo delivery of siRNA to hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(32):12982-12987.
149. Russ V., Elfberg H., Thoma C., Kloeckner J., Ogris M., Wagner E. Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for invitro and invivo gene transfer. Gene Therapy 2008, 15(1):18-29.
150. Russ V., Frohlich T., Li Y., Halama A., Ogris M., Wagner E. Improved invivo gene transfer into tumor tissue by stabilization of pseudodendritic oligoethylenimine-based polyplexes. The Journal of Gene Medicine 2010, 12(2):180-193. 10.1002/jgm.1430.
151. Russ V., Gunther M., Halama A., Ogris M., Wagner E. Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. The Journal of Controlled Release 2008, 132(2):131-140. pii:S0168-3659(08)00524-5. 10.1016/j.jconrel.2008.09.003.
152. Saito G., Amidon G.L., Lee K.D. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Therapy 2003, 10(1):72-83.
153. Salcher E.E., Kos P., Frohlich T., Badgujar N., Scheible M., Wagner E. Sequence-defined four-arm oligo(ethanamino)amides for pDNA and siRNA delivery: Impact of building blocks on efficacy. The Journal of Controlled Release 2012, 164(3):380-386. pii:S0168-3659(12)00523-8. 10.1016/j.jconrel.2012.06.023.
154. Sato T., Ishii T., Okahata Y. Invitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001, 22(15):2075-2080.
155. Schaffert D., Badgujar N., Wagner E. Novel Fmoc-polyamino acids for solid-phase synthesis of defined polyamidoamines. Organic Letters 2011, 13(7):1586-1589. 10.1021/ol200381z.
156. Schaffert D., Troiber C., Salcher E.E., Frohlich T., Martin I., Badgujar N., et al. Solid-phase synthesis of sequence-defined T-, i-, and U-shape polymers for pDNA and siRNA delivery. Angewandte Chemie International Edition in English 2011, 50(38):8986-8989. 10.1002/anie.201102165.
157. Schaffert D., Troiber C., Wagner E. New sequence-defined Polyaminoamides with Tailored endosomolytic properties for plasmid DNA delivery. Bioconjugate Chemistry 2012, 23(6):1157-1165. 10.1021/bc200614x.
158. Schaffert D., Wagner E. Gene therapy progress and prospects: synthetic polymer-based systems. Gene Therapy 2008, 15(16):1131-1138.
159. Schatzlein A.G. Targeting of synthetic gene delivery systems. Journal of Biomedicine and Biotechnology 2003, 2003(2):149-158.
160. Schatzlein A.G., Zinselmeyer B.H., Elouzi A., Dufes C., Chim Y.T.A., Roberts C.J., et al. Preferential liver gene expression with polypropylenimine dendrimers. The Journal of Controlled Release 2005, 101(1-3):247-258.
161. Scholz C., Kos P., Leclercq L., Jin X., Cottet H., Wagner E. Correlation of length of linear Oligo(ethanamino) amides with gene Transfer and cytotoxicity. ChemMedChem 2014, 9(9):2104-2110. 10.1002/cmdc.201300483.
162. Scholz C., Wagner E. Therapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers. The Journal of Controlled Release 2012, 161(2):554-565. pii:S0168-3659(11)01044-3. 10.1016/j.jconrel.2011.11.014.
163. Schreiber S., Kampgen E., Wagner E., Pirkhammer D., Trcka J., Korschan H., et al. Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study. Human Gene Therapy 1999, 10(6):983-993.
164. Sidi A.A., Ohana P., Benjamin S., Shalev M., Ransom J.H., Lamm D., et al. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. The Journal of Urology 2008, 180(6):2379-2383. pii:S0022-5347(08)02059-4. 10.1016/j.juro.2008.08.006.
165. De Smedt S.C., Demeester J., Hennink W.E. Cationic polymer based gene delivery systems. Pharmaceutical Research 2000, 17(2):113-126.
166. Smull C.E., Ludwig E.H. Enhancement of the plaque forming capacity of poliovirus ribonucleic acid with basic proteins. Journal of Bacteriology 1962, 84:1035-1040.
167. Sonawane N.D., Szoka F.C., Verkman A.S. Chloride accumulation and swelling in endosomes enhances DNA Transfer by Polyamine-DNA polyplexes. The Journal of Biological Chemistry 2003, 278(45):44826-44831.
168. Stevenson M., Ramos-Perez V., Singh S., Soliman M., Preece J.A., Briggs S.S., et al. Delivery of siRNA mediated by histidine-containing reducible polycations. The Journal of Controlled Release 2008, 130(1):46-56.
169. Takemoto H., Miyata K., Nishiyama N., Kataoka K. Bioresponsive polymer-based nucleic acid carriers 2014, (Chapter in current volume).
170. Takeshita F., Minakuchi Y., Nagahara S., Honma K., Sasaki H., Hirai K., et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen invivo. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(34):12177-12182.
171. Tang M.X., Szoka F.C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Therapy 1997, 4:823-832.
172. Tarcha P.J., Pelisek J., Merdan T., Waters J., Cheung K., von Gersdorff K., et al. Synthesis and characterization of chemically condensed oligoethylenimine containing beta-aminopropionamide linkages for siRNA delivery. Biomaterials 2007, 28(25):3731-3740.
173. Thanou M., Florea B.I., Geldof M., Junginger H.E., Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 2002, 23(1):153-159.
174. Tietze N., Pelisek J., Philipp A., Roedl W., Merdan T., Tarcha P., et al. Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran. Oligonucleotides 2008, 18(2):161-174.
175. Troiber C., Edinger D., Kos P., Schreiner L., Klager R., Herrmann A., et al. Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes. Biomaterials 2013, 34(5):1624-1633. pii:S0142-9612(12)01265-3. 10.1016/j.biomaterials.2012.11.021.
176. Uchida H., Miyata K., Oba M., Ishii T., Suma T., Itaka K., et al. Odd-even effect of repeating aminoethylene units in the side chain of N-substituted polyaspartamides on gene transfection profiles. Journal of the American Chemical Society 2011, 133(39):15524-15532. 10.1021/ja204466y.
177. Vaheri A., Pagano J.S. Infectious poliovirus RNA: a sensitive method of assay 2. Virology 1965, 27(3):434-436.
178. van der Aa M.A., Koning G.A., d'Oliveira C., Oosting R.S., Wilschut K.J., Hennink W.E., et al. An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems. The Journal of Gene Medicine 2005, 7(2):208-217.
179. Wadhwa M.S., Knoell D.L., Young A.P., Rice K.G. Targeted gene delivery with a low molecular weight glycopeptide carrier. Bioconjugate Chemistry 1995, 6:283-291.
180. Wagner E. Effects of membrane-active agents in gene delivery. The Journal of Controlled Release 1998, 53(1-3):155-158.
181. Wagner E. Strategies to improve DNA polyplexes for invivo gene transfer: will "artificial viruses" be the answer?. Pharmaceutical Research 2004, 21(1):8-14.
182. Wagner E. Programmed drug delivery: nanosystems for tumor targeting. Expert Opinion on Biological Therapy 2007, 7(5):587-593.
183. Wagner E. Converging Paths of viral and non-viral vector engineering. Molecular Therapy 2008, 16(1):1-2.
184. Wagner E. Functional Polymer Conjugates for Medicinal Nucleic Acid DeliveryPolymers in Nanomedicine 2012, Vol. 247:1-29. Springer, Berlin/Heidelberg. S. Kunugi, T. Yamaoka (Eds.).
185. Wagner E. Polymers for siRNA Delivery: Inspired by viruses to be targeted, dynamic, and precise. Accounts of Chemical Research 2012, 45(7):1005-1013. 10.1021/ar2002232.
186. Wagner E., Culmsee C., Boeckle S. Targeting of polyplexes: toward synthetic virus vector systems. Advances in Genetics 2005, 53:333-354.
187. Wagner E., Kloeckner J. Gene delivery using polymer therapeutics. Advances in Polymer Science 2006, 192:135-173.
188. Wagner E., Plank C., Zatloukal K., Cotten M., Birnstiel M.L. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(17):7934-7938.
189. Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D.T., et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(13):6099-6103.
190. Wagner E., Zenke M., Cotten M., Beug H., Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(9):3410-3414.
191. Walker G.F., Fella C., Pelisek J., Fahrmeir J., Boeckle S., Ogris M., et al. Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer invitro and invivo. Molecular Therapy 2005, 11(3):418-425.
192. Walsh M., Tangney M., O'Neill M.J., Larkin J.O., Soden D.M., McKenna S.L., et al. Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: implications for cancer gene therapy. Molecular Pharmaceutics 2006, 3(6):644-653.
193. Wang P., Dong S., Shieh J.H., Peguero E., Hendrickson R., Moore M.A., et al. Erythropoietin derived by chemical synthesis. Science 2013, 342(6164):1357-1360. 10.1126/science.1245095.
194. Wang X.L., Jensen R., Lu Z.R. A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery. The Journal of Controlled Release 2007, 120(3):250-258.
195. Wang H., Liu K., Chen K.J., Lu Y., Wang S., Lin W.Y., et al. A rapid pathway toward a superb gene delivery system: programming structural and functional diversity into a supramolecular nanoparticle library. ACS Nano 2010, 4(10):6235-6243. 10.1021/nn101908e.
196. Whitehead K.A., Dorkin J.R., Vegas A.J., Chang P.H., Veiseh O., Matthews J., et al. Degradable lipid nanoparticles with predictable invivo siRNA delivery activity. Nature Communications 2014, 5:4277. 10.1038/ncomms5277.
197. Wightman L., Kircheis R., Rossler V., Carotta S., Ruzicka R., Kursa M., et al. Different behavior of branched and linear polyethylenimine for gene delivery invitro and invivo. The Journal of Gene Medicine 2001, 3(4):362-372.
198. Wolff J.A., Rozema D.B. Breaking the bonds: non-viral vectors become chemically dynamic. Molecular Therapy 2008, 16(1):8-15.
199. Wu G.Y., Wu C.H. Receptor-mediated invitro gene transformation by a soluble DNA carrier system. The Journal of Biological Chemistry 1987, 262:4429-4432.
200. Wu G.Y., Wu C.H. Receptor-mediated gene delivery and expression invivo. The Journal of Biological Chemistry 1988, 262:14621-14624.
201. Young S., Wong M., Tabata Y., Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. The Journal of Controlled Release 2005, 109(1-3):256-274.
202. Yu H., Russ V., Wagner E. Influence of the molecular weight of bioreducible oligoethylenimine conjugates on the polyplex transfection properties. AAPS Journals 2009, 11(3):445-455. 10.1208/s12248-009-9122-3.
203. Yu H., Wagner E. Bioresponsive polymers for nonviral gene delivery. Current Opinions in Molecular Therapy 2009, 11(2):165-178.
204. Yu H., Wang W., Chen X., Deng C., Jing X. Synthesis and characterization of the biodegradable polycaprolactone-graft-chitosan amphiphilic copolymers. Biopolymers 2006, 83(3):233-242.
205. Zanta M.A., Belguise V.P., Behr J.P. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(1):91-96.
206. Zauner W., Blaas D., Kuechler E., Wagner E. Rhinovirus-mediated endosomal release of transfection complexes. Journal of Virology 1995, 69(2):1085-1092.
207. Zauner W., Ogris M., Wagner E. Polylysine-based transfection systems utilizing receptor-mediated delivery. Advanced Drug Delivery Reviews 1998, 30(1-3):97-113.
208. Zhang C.Y., Kos P., Muller K., Schrimpf W., Troiber C., Lachelt U., et al. Native chemical ligation for conversion of sequence-defined oligomers into targeted pDNA and siRNA carriers. The Journal of Controlled Release 2014, 180:42-50. 10.1016/j.jconrel.2014.02.015.
209. Zinselmeyer B.H., Mackay S.P., Schatzlein A.G., Uchegbu I.F. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharmaceutical Research 2002, 19(7):960-967.
210. Zintchenko A., Philipp A., Dehshahri A., Wagner E. Simple modifications of branched PEI Lead to highly efficient siRNA carriers with low toxicity. Bioconjugate Chemistry 2008, 19(7):1448-1455.
211. Zou S.M., Erbacher P., Remy J.S., Behr J.P. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. The Journal of Gene Medicine 2000, 2(2):128-134.
212. Zuber G., Dauty E., Nothisen M., Belguise P., Behr J.P. Towards synthetic viruses. Advanced Drug Delivery Reviews 2001, 52(3):245-253.